ImaRx Therapeutics, Inc.

(NASDAQ:IMRX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Operating revenue
Total Revenue 1,683 2,146 1,944 2,650
Operating Revenue 1,683 2,146 1,944 2,650
Adjustments To Revenue — — — —
Cost Of Sales 620 764 547 715
Cost Of Sales With Depreciation 717 925 834 989
Gross Operating Profit 1,063 1,382 1,397 1,935
Operating Expenses
Research And Development Expenses 352 1,033 1,567 2,141
Selling General And Administrative Expenses 829 2,994 1,994 1,705
Advertising Expenses — — — —
Operating Income Before Depreciation -118 -2,645 -2,164 -1,911
Operating Income -215 -12,784 -2,451 -2,185
Depreciation 97 161 287 274
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles — — — —
Operating Income After Depreciation -215 -2,806 -2,451 -2,185
Non Operating Expenses
Interest Expense — 30 173 187
Pre Tax Income -216 -7,270 -2,530 -2,213
Income Taxes — — — —
Minority Interest — — — —
Income Before Income Taxes — — — —
Net Income From Continuing Operations -216 -7,270 -2,530 -2,213
Net Income From Discontinued Operations — — — —
Net Income From Total Operations -216 -7,270 -2,530 -2,213
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income -216 -7,270 -2,530 -2,213
Normalized Income -216 -2,894 -2,530 -2,213
NetIncome Available For Common -216 -7,270 -2,530 -2,213
Preferred Dividends — — — —
Excise Taxes — — — —